SCHEMBL30435255

SCHEMBL30435255

NC(=O)C[C@H](NC(=O)[C@@H](N)CCC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)N1CCC[C@H]1C(=O)O

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ACE P12821 6/20 0.51
▸ REN P00797 4/20 0.51
▸ DPP4 P27487 2/20 0.43
▸ FAP Q12884 1/20 0.43
▸ DPP8 Q6V1X1 1/20 0.43
▸ DPP9 Q86TI2 1/20 0.43
▸ DPP7 Q9UHL4 1/20 0.43
▸ F2R P25116 2/20 0.40
▸ CTSD P07339 2/20 0.40
▸ BACE1 P56817 2/20 0.40
▸ KDM4E B2RXH2 1/20 0.39
▸ F2 P00734 1/20 0.39
▸ LMNA P02545 1/20 0.39
▸ LTA4H P09960 1/20 0.39
▸ MAPT P10636 1/20 0.39
▸ PEPD P12955 1/20 0.39
▸ ALOX15 P16050 1/20 0.39
▸ PTGS1 P23219 1/20 0.39
▸ HTR2A P28223 1/20 0.39
▸ PTGS2 P35354 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30435414 1.00 ACE (0.51) ACERENDPP4FAPDPP8
SCHEMBL1323636 0.95 ACE (0.56) ACERENDPP4FAPDPP8
SCHEMBL12120319 0.95 ACE (0.56) ACERENDPP4FAPDPP8
SCHEMBL30435421 0.89 ACE (0.52) ACERENDPP4F2RKDM4E
SCHEMBL31073517 0.88 ACE (0.54) ACERENDPP4FAPDPP8
SCHEMBL29834944 0.88 ACE (0.53) ACERENDPP4KDM4EF2
SCHEMBL30264477 0.88 ACE (0.59) ACERENDPP4FAPDPP8
SCHEMBL30434949 0.88 ACE (0.55) ACERENDPP4FAPDPP8
SCHEMBL29349605 0.87 ACE (0.54) ACERENKDM4EF2LMNA
SCHEMBL30165187 0.87 F2R (0.47) ACERENF2RKDM4EF2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250134947-A1 TRI-, TETRA AND PENTAPEPTIDES, COMPOSITIONS THEREOF AND THEIR USE IN THE THERAPY OF PSORIASIS ENUMITA AS (NO) 2025-05-01 — — US claimed
EP-4426715-A1 TRI-, TETRA AND PENTAPEPTIDES, COMPOSITIONS THEREOF AND THEIR USE IN THE THERAPY OF PSORIASIS Enumita AS (NO) 2024-09-11 — — EP claimed
WO-2023080790-A1 TRI-, TETRA AND PENTAPEPTIDES, COMPOSITIONS THEREOF AND THEIR USE IN THE THERAPY OF PSORIASIS TOSOJ AS (NO) 2023-05-11 — — WO claimed
US-20250134947-A1 TRI-, TETRA AND PENTAPEPTIDES, COMPOSITIONS THEREOF AND THEIR USE IN THE THERAPY OF PSORIASIS ENUMITA AS (NO) 2025-05-01 — — US disclosed
EP-4426715-A1 TRI-, TETRA AND PENTAPEPTIDES, COMPOSITIONS THEREOF AND THEIR USE IN THE THERAPY OF PSORIASIS Enumita AS (NO) 2024-09-11 — — EP disclosed
WO-2023080790-A1 TRI-, TETRA AND PENTAPEPTIDES, COMPOSITIONS THEREOF AND THEIR USE IN THE THERAPY OF PSORIASIS TOSOJ AS (NO) 2023-05-11 — — WO disclosed
Send feedback